Basic Cardizem Information

• INN (International Nonproprietary Name): Diltiazem
• Brand names available in Canada: Cardizem, Cardizem CD/LA, Cartia XT
• ATC Code: C08DB01
• Forms & dosages: Tablets (30 mg, 60 mg, 90 mg, 120 mg), Extended-release capsules/tablets (60 mg, 90 mg, 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, 420 mg)
• Manufacturers in Canada: Bausch Health, Mylan, Teva, among others
• Registration status in Canada: Prescription only (Rx)
• OTC / Rx classification: Prescription Only (Rx)

Availability & Price Landscape

Across Canada, Cardizem is a medication you can find at major pharmacy chains, including Shoppers Drug Mart, Rexall, and London Drugs. A range of forms is available, such as immediate-release and extended-release tablets. Depending on the province, you might see variations in availability. Some retailers offer both brand and generic versions, giving patients options based on their preferences.

Online Pharmacy Trends in Canada

With the increasing shift towards online pharmacy shopping, Canadians are leveraging e-pharmacies for their medication needs. However, it’s essential to note that the availability of Cardizem online can be impacted by federal and provincial regulations. For instance, regions like Ontario and British Columbia have specific regulations governing what types of medications can be dispensed online. This means when ordering Cardizem through an online pharmacy, potential buyers must ensure that the pharmacy complies with local laws, as restrictions can vary across provinces.

Price Ranges by Package Size

When it comes to the cost, you can expect significant regional variations in the price of Cardizem. The price for a 30-day supply of 120 mg tablets can range from approximately $40 to $100 CAD. This fluctuation often depends on the pharmacy and applicable health plan coverage. Public drug programs such as the Ontario Drug Benefit and BC PharmaCare may also help reduce costs for eligible patients, making this medication more accessible for those in need. Always consider comparing prices between local pharmacies and online platforms to ensure you’re getting the best deal on your Cardizem prescription.

Canadian Patient Insights & Satisfaction Levels

Community forums like Reddit Canada, HealthBoards, and AskDocs have become go-to resources for many Canadians seeking insights about Cardizem. Discussions highlight a blend of both satisfaction regarding symptom management and concerns regarding potential side effects, showcasing the diverse patient experiences with this medication.

Reported Benefits and Challenges from Canadian Patients

Patients report substantial benefits from Cardizem, particularly in controlling symptoms associated with chronic angina and hypertension. That said, some challenges do arise. Common side effects can include headaches and dizziness, which many users discuss openly in forums. It seems that effective dosage management is crucial for maintaining overall satisfaction with the medication and minimizing adverse effects. By understanding the benefits and challenges shared by other patients, individuals considering Cardizem can better navigate their treatment. Adequate discussion with healthcare providers remains essential for finding the right dosage and understanding any potential side effects associated with Cardizem.

Product Overview & Brand Variants

The International Nonproprietary Name (INN) for Cardizem is Diltiazem. It’s marketed in Canada under several brand names, such as Cardizem, Cardizem CD/LA, and Cartia XT. Each formulation presents unique characteristics tailored to meet various medical needs, offering options for those requiring immediate or extended release of the medication.

Legal Classification Under Health Canada

In Canada, Cardizem is classified as a prescription-only medication regulated by Health Canada. This classification ensures that healthcare providers authorize this medication, emphasizing the importance of monitoring and proper dosage management for all patients. Following guidelines set by Health Canada helps safeguard patient health and ensures that the medication is used effectively within its approved indications.

Indications in Local Canadian Medical Practice

Cardizem is primarily approved for the management of chronic angina pectoris and hypertension. Health Canada has conducted a thorough evaluation of these medical indications, granting a Drug Identification Number (DIN). This helps confirm that the medication is regulated and deemed safe for these specific conditions.

Approved Uses (Health Canada DIN Context)

The primary therapeutic applications of Cardizem involve:

• Chronic angina pectoris: Reducing pain and improving exercise tolerance.
• Hypertension: Aiding in maintaining lower blood pressure levels over time.

Having an official DIN from Health Canada means these uses have undergone extensive clinical trials and regulatory review, ensuring safe use in the Canadian population.

Off-Label Patterns in Canadian Healthcare

In some cases, healthcare providers may prescribe Cardizem off-label for other conditions, which can include:

• Atrial fibrillation: To help control your heart's rhythm.
• Tachycardia: Addressing excessively rapid heartbeats.

Patients are always encouraged to discuss with their healthcare professionals the implications and potential risks of using Cardizem for conditions outside its approved indications.

How It Works in the Body

Understanding how Cardizem works will help clarify its benefits. The active ingredient, diltiazem, operates as a calcium channel blocker. This means it prevents calcium ions from entering heart and blood vessel cells.

Layman’s Explanation (Canadian Patient-Friendly Tone)

This blockage leads to the relaxation of blood vessels, which in turn lowers blood pressure and lessens the workload on the heart. The effect is a reduction in angina symptoms, making daily activities easier and more comfortable.

Clinical Detail from Health Canada Resources

From a more technical standpoint, Cardizem regulates calcium ion influx during both electrical conduction and muscle contraction in the heart. This regulation is vital for maintaining stable heart rhythms and supporting overall cardiovascular health.

Dosage & Administration

When it comes to dosing, understanding the standard regimens is crucial for both patients and healthcare providers. The typical dosages of Cardizem range from 120 to 240 mg daily, tailored to the specific health condition being treated.

Standard Regimens per Canadian Guidelines

Cardizem is available in various forms:

• Immediate-release tablets
• Extended-release capsules

The extended-release formulations allow for once-daily administration, streamlining treatment plans for patients.

Adjustments by Patient Type (With Canadian Clinical Notes)

Dosage adjustments are often necessary for specific populations:

• The elderly: It’s advised to start with lower doses to mitigate side effects.
• Patients with liver or kidney impairments: Close monitoring and possible dose reductions may be required.

These customizations ensure the medication remains effective while minimizing risks, allowing for safe and practical use in diverse patient demographics.

Contraindications & Side Effects

Like any medication, Cardizem comes with a profile of potential side effects. Understanding these can help patients make informed choices and enhance adherence to their treatment plans.

Common (Health Canada-Approved List)

Commonly reported side effects include:

• Headaches
• Dizziness
• Fatigue

Such reactions are generally mild and may alleviate as the body grows accustomed to the medication. It's important for individuals to communicate any persistent side effects with their healthcare provider.

Rare but Serious (With Canadian Pharmacovigilance Data)

On the rare side of the spectrum, some serious adverse reactions can occur, such as:

• Severe hypotension
• Bradycardia

Health Canada’s pharmacovigilance networks vigilantly monitor these adverse events. This ensures that any concerns are quickly communicated to keep patients safe.

Comparable Medicines in Canada

Finding alternatives to Cardizem can be crucial for patients exploring treatment options. Here are some comparable medicines available in Canada, alongside their notable features.

Alternatives Table (With DIN References)

Alternative Medicine	DIN Reference	Notable Features
Amlodipine	02324575	Once-daily dosing for hypertension
Verapamil	00863110	Effective for angina and arrhythmia
Nifedipine	02075937	Rapid-acting options available

Pros and Cons List

Using Cardizem comes with its own set of benefits and drawbacks:

• Pros: Specific targeting of cardiovascular symptoms.
• Established safety profile: Supported by years of clinical use.

• Cons: Potential for side effects, including headaches and dizziness.
• Interactions: May engage negatively with other medications; frequent monitoring is necessary.

Understanding these factors can aid patients and healthcare providers in making informed decisions about treatment options.

Current Research & Trends

Recent studies reflect an evolving approach to cardiovascular care. Between 2022 and 2025, research has investigated Cardizem’s effectiveness in managing chronic pain related to cardiovascular conditions, showcasing its versatility. Numerous clinical trials conducted in Canada are exploring new indications for Diltiazem, revealing opportunities to enhance treatment for diverse patient populations.

Common Patient Questions in Canada

Patients often grapple with various concerns regarding their prescribed Cardizem:

• Is Cardizem safe to take with other medications? Risks of interactions must be assessed by healthcare providers.
• How can I manage side effects like headaches or dizziness? Consulting a doctor can help tailor supportive care.
• What should I do if I miss a dose? If a dose is missed, it should be taken as soon as remembered but skipped if it’s close to the next dose.

Addressing these FAQs promotes better patient compliance and overall treatment efficacy.

Regulatory Status

Health Canada Approval Process

Health Canada rigorously reviews medications, ensuring that Cardizem meets established safety and efficacy standards. Through extensive clinical trials, the approval process for Diltiazem ensures that patients receive reliable treatment options aligned with Canadian health policies.

DIN Number Relevance

The Drug Identification Number (DIN) is crucial for the identification of Cardizem in Canada. This number represents that the product adheres to Health Canada’s strict guidelines, providing essential assurance to both patients and healthcare providers regarding the drug's safety and effectiveness.

Visual Recommendations

Infographic Ideas for Canadian Context

Utilising infographics can significantly enhance patient understanding. Ideas include:

• Visuals detailing Cardizem's approved uses and dosage guidelines.
• Infographics that outline common side effects for effective patient education.
• Diagrams comparing Cardizem with its alternatives.

These aids can bolster patient comprehension and adherence to treatment regimens.

Buying & Storage Advice

In-Store vs. Online Canadian Purchase Tips

When it comes to purchasing Cardizem, patients should compare prices between local pharmacies and reputable online retailers. Not only is price important, but ensuring that pharmacies comply with provincial regulations fosters safety during the purchasing process.

Proper Storage with Canadian Climate Considerations

Keeping Cardizem effective involves proper storage. It should be kept at room temperature (20–25°C) and protected from moisture and light. In warmer months, extra caution is necessary during transport to prevent temperature fluctuations that could affect the drug’s efficacy.

Guidelines for Proper Use

Canadian Doctor/Pharmacist Advice Style

Healthcare professionals advise patients to take Cardizem consistently—preferably at the same time each day. Adhering to prescribed dosages is crucial, and regular check-ins with healthcare providers can ensure ongoing safety and effectiveness. This approach can lead to better management of cardiovascular conditions.

City	Region	Delivery Time
Toronto	Ontario	5–7 days
Vancouver	British Columbia	5–7 days
Calgary	Alberta	5–7 days
Montreal	Quebec	5–7 days
Ottawa	Ontario	5–7 days
Edmonton	Alberta	5–7 days
Winnipeg	Manitoba	5–7 days
Halifax	Nova Scotia	5–9 days
Victoria	British Columbia	5–9 days
Regina	Saskatchewan	5–9 days
St. John’s	Newfoundland	5–9 days
London	Ontario	5–7 days
Quebec City	Quebec	5–9 days